Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_assertion type Assertion NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_head.
- NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_assertion description "[GIP response to SFA ingestion is prolonged in nondiabetic patients with NASH and is correlated with liver disease, an unfavorable dynamic adipokine profile, and beta cell dysfunction, which provides a rationale for GIP antagonism in these subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_provenance.
- NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_assertion evidence source_evidence_literature NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_provenance.
- NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_assertion SIO_000772 19141695 NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_provenance.
- NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_assertion wasDerivedFrom gad-20130706 NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_provenance.
- NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_assertion wasGeneratedBy ECO_0000203 NP80999.RAKEfF1719L7pyvnQ08JZREroda5PM4q5HGwZI2DWRscg130_provenance.